Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;139(5):675-683.
doi: 10.1097/ALN.0000000000004711.

Early Fibrinogen Replacement to Treat the Endotheliopathy of Trauma: Novel Resuscitation Strategies in Severe Trauma

David J Douin  1 , Ana Fernandez-Bustamante  1
Affiliations

Early Fibrinogen Replacement to Treat the Endotheliopathy of Trauma: Novel Resuscitation Strategies in Severe Trauma

David J Douin et al. Anesthesiology. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Conceptual model of restoration of endothelial integrity via fibrinogen replacement following trauma
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention: Leading Causes of Death and Injury. Published Online March 11, 2022 2022; https://www.cdc.gov/injury/wisqars/LeadingCauses.html
    1. Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. Journal of Trauma and Acute Care Surgery 2006; 60: S3–11 - PubMed
    1. Wu F, Chipman A, Pati S, Miyasawa B, Corash L, Kozar RA: Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient. Shock 2020; 53: 575–584 - PMC - PubMed
    1. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH, Group PS: The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surgery 2013; 148: 127–36 - PMC - PubMed
    1. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O’Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G, Group PS: Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313: 471–82 - PMC - PubMed

Publication types